Table 3 Comparison of risk predicted from established models among Chinese patients with ultra-high, high, low and ultra-low risk based on quartile risk classification of 70-gene signature test
Risk calculated from established models | 70-gene ultrahigh risk N = 12 (%) 4 | 70-gene high risk N = 50 (%) 3 | 70-gene low risk N = 65 (%) 2 | 70-gene ultralow risk N = 23 (%) 1 | P-value |
|---|---|---|---|---|---|
AOL | Â | Â | Â | Â | 0.861& |
 High (1) | 9 (75.0) | 37 (74.0) | 44 (67.7) | 17 (73.9) |  |
 Low (0) | 3 (25.0) | 13 (26.0) | 21 (32.3) | 6 (26.1) |  |
CTS5 | Â | Â | Â | Â | 0.162 |
 Score (Mean ± SD) | 3.34 ± 0.41 | 3.28 ± 0.62 | 3.14 ± 0.63 | 3.13 ± 0.66 |  |
CTS5 | Â | Â | Â | Â | 0.250^ |
 High (2) | 1 (8.3) | 7 (14.0) | 9 (13.8) | 3 (13.0) |  |
 Intermediate (1) | 8 (66.7) | 25 (50.0) | 22 (33.8) | 7 (30.4) |  |
 Low (0) | 3 (25.0) | 18 (36.0) | 34 (52.3) | 13 (56.5) |  |
IHC3 |  |  |  |  |  < 0.001^ |
 High (1) | 10 (83.3) | 17 (34.0) | 10 (15.4) | 0 (0.0) |  |
 Low (0) | 2 (16.7) | 33 (66.0) | 55 (84.6) | 23 (100.0) |  |
NPI |  |  |  |  |  < 0.001 |
 Score (Mean ± SD) | 4.83 ± 0.58 | 4.52 ± 0.45 | 4.34 ± 0.46 | 4.18 ± 0.65 |  |
NPI | Â | Â | Â | Â | 0.768^ |
 Poor (2) | 0 (0.0) | 1 (1.5) | 0 (0.0) | 0 (0.0) |  |
 Moderate (1) | 9 (75.0) | 39 (78.0) | 43 (66.2) | 17 (73.9) |  |
 Good (0) | 3 (25.0) | 11 (22.0) | 21 (32.3) | 6 (26.1) |  |